E.U. Agency in Limbo as Hidden Costs of ‘Brexit’ Continue to Mount The likely move of the European Medicines Agency, currently in Britain, has worrying implications for the country’s vibrant biotech and pharmaceuticals sector. Share: Facebook Twitter Google+ Stumble Digg Email ThisBlogThis!Share to XShare to Facebook Related Posts:Marine Le Pen Draws Cheers in Macron’s Hometown, and He Gets BoosChided by Brussels, Hungary’s Leader Attacks George SorosAgustín Edwards, Conservative Media Tycoon in Chile, Is Dead at 89Protests, Taliban and a Warlord’s Return: Afghan Leader Faces a Tough Year AheadWhite House Is Said to Draft Plan for U.S. Break From NaftaAsia and Australia Edition: China, Donald Trump, Pope Francis: Your Morning Briefing
